Terug
Dagbereik
€ 122,22
€ 126,99
52-Weeksbereik
€ 68,70
€ 155,53
Volume
1.308.771
50D / 200D Gem.
€ 131,49
/
€ 113,06
Vorige Slotkoers
€ 124,33
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 22,3 | 0,4 |
| P/B | 7,0 | 2,9 |
| ROE % | 33,4 | 3,7 |
| Net Margin % | 19,6 | 3,8 |
| Rev Growth 5Y % | -1,0 | 10,0 |
| D/E | 0,9 | 0,2 |
Belangrijkste Punten
Revenue declined -1,03% annually over 5 years
ROE of 33,36% indicates high profitability
Net margin of 19,58% shows strong profitability
Generating 931,00M in free cash flow
Cash machine — converts 109,53% of earnings into free cash flow
Capital efficient — spends only 3,41% of revenue on capex
Groei
Revenue Growth (5Y)
-1,03%
Revenue (1Y)-0,69%
Earnings (1Y)N/A
FCF Growth (3Y)81,70%
Kwaliteit
Return on Equity
33,36%
ROIC12,30%
Net Margin19,58%
Op. Margin19,92%
Veiligheid
Debt / Equity
0,94
Current Ratio2,08
Interest Coverage8,65
Waardering
P/E Ratio
22,27
P/B Ratio6,95
EV/EBITDA23,19
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,69% | Revenue Growth (3Y) | -1,81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1,03% | Earnings Growth (5Y) | 2,77% |
| Profitability | |||
| Revenue (TTM) | 4,34B | Net Income (TTM) | 850,00M |
| ROE | 33,36% | ROA | 12,79% |
| Gross Margin | 66,49% | Operating Margin | 19,92% |
| Net Margin | 19,58% | Free Cash Flow (TTM) | 931,00M |
| ROIC | 12,30% | FCF Growth (3Y) | 81,70% |
| Safety | |||
| Debt / Equity | 0,94 | Current Ratio | 2,08 |
| Interest Coverage | 8,65 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 22,27 | P/B Ratio | 6,95 |
| P/S Ratio | 4,36 | PEG Ratio | -0,14 |
| EV/EBITDA | 23,19 | Dividend Yield | 0,00% |
| Market Cap | 18,93B | Enterprise Value | 20,06B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,34B | 4,37B | 4,50B | 4,58B | 4,53B |
| Net Income | 850,00M | -1,22B | -1,16B | -4,40B | 762,00M |
| EPS (Diluted) | 5,44 | -7,69 | -7,35 | -28,05 | 5,05 |
| Gross Profit | 2,89B | 2,86B | 2,74B | 2,97B | 3,15B |
| Operating Income | 865,00M | -833,00M | -1,07B | -4,18B | -123,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,64B | 6,30B | 10,11B | 12,25B | 15,22B |
| Total Liabilities | 3,92B | 3,93B | 4,37B | 5,65B | 4,48B |
| Shareholders' Equity | 2,72B | 2,37B | 5,75B | 6,60B | 10,74B |
| Total Debt | 2,55B | 2,62B | 2,26B | 3,56B | 2,54B |
| Cash & Equivalents | 1,42B | 1,13B | 1,05B | 2,01B | 1,23B |
| Current Assets | 3,29B | 2,75B | 2,61B | 3,56B | 2,71B |
| Current Liabilities | 1,59B | 1,55B | 1,57B | 2,77B | 1,09B |